课题基金 / 基金详情

CYP2B6 POLYMORPHISMS: NEVIRAPINE/EFAVIRENZ METABOLISM

CYP2B6 POLYMORPHISMS: NEVIRAPINE/EFAVIRENZ METABOLISM
CYP2B6 多态性：奈韦拉平/依非韦伦代谢
批准号：
7731393
负责人：
David W Haas
金额：
$1.11万
依托单位：
VANDERBILT UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-09-16
来源：
https://reporter.nih.gov/project-details/7731393
关键词：
Acquired Immunodeficiency SyndromeCYP2B6 geneComputer Retrieval of Information on Scientific Projects DatabaseFundingGeneticGenetic PolymorphismGrantInstitutionMetabolismNevirapinePopulationResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthdrug metabolismefavirenz

项目摘要

项目成果

David W Haas的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Regarding AIDS Hypothesis: Interindividual and population differences in drug metabolism and dispotion of efavirenz and nevirapine are a consequence of genetic variability in CYP2B6
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt CTU SARS-CoV-2 Supplement
Clinical Sciences Core (Core C)
Clinical Sciences Core (Core C)
Clinical Sciences Core (Core C)